SATYA PHARMA INNOVATIONS – An Oncology Biotech

An Oncology biotech pioneering RAD51 inhibition and other DDR mechanisms

HOME
SCIENCE
TEAM
PIPELINE
NEWS
CAREERS
CONTACT US

News

Home
News

January 5, 2023
4:10 am

Satya is at JPM, 2023

Please set up meetings with CSN at murthcsn@satyarx.com

Leave A Comment

Recent News

Satya is at BIO, 2023 – Boston, June 3-6

20 Aug,2024
Satya @ JPM 2024

20 Aug,2024
Satya is at BIO, 2023 – Boston, June 3-6

20 Aug,2024

Satya combines AI with traditional drug discovery to deeply understand target biology, using vast literature, curated databases, and models to analyze ligand-protein interactions. We focus on critical pathways affecting large patient groups, targeting cell cycle, DNA repair, or metabolic processes. Our goal is to modulate these pathways to treat diseases like cancer, inflammation, and metabolic disorders. We aim to minimize impact on normal cells, creating transformative drugs.

Quick Links

Home
Science
Team
PipeLine
News

Contact

Email

roshini.j@satyarx.com
Location

CDC Towers, 3rd Floor, Block B Plot No. 10/8, Road No. 5 Nacharam, HYDERABAD 500 076

Copyright ©2025 Satyarx. All rights reserved.

Trems & Condition
Privacy Policy
Contact Us

roshini.j@satyarx.com

search here

Go Back Top